Servier Middle East

Servier Middle East is dedicated to serving health as a global pharmaceutical group, driven by a Foundation committed to making a meaningful social impact for patients and a sustainable world. With a unique governance model, Servier Middle East focuses on long-term therapeutic progress, committed to fulfilling patient needs. The company operates from its primary location at Dubai Science Park, South Tower, Dubai, Dubai 485015, AE.

As a world leader in cardiology, Servier Middle East aspires to be a focused and innovative player in oncology, targeting hard-to-treat cancers. The Group allocates over 70% of its R&D budget to developing targeted and innovative therapies in oncology. Neuroscience and immuno-inflammatory diseases are the future growth drivers, with Servier Middle East concentrating on diseases where accurate patient profiling enables precision medicine.

Servier Middle East also promotes access to quality care for all at a lower cost, offering a range of quality generic drugs covering most pathologies. With a strong geographical footprint in over 150 countries, Servier Middle East integrates the patient voice at each stage of medicine's life cycle. We invite the manager of Servier Middle East to create a customized and exclusive company showcase and product listing on our platform to further enhance its presence and reach.